Risk management is first and foremost about protecting patients. Urine drug testing (UDT) in particular, is a core constituent in an effective, comprehensive strategy to reduce risk management when prescribing controlled substances, especially opiates. Urine drug testing is a tool to help clinicians and patients make better choices in screening, early identification of misuse of substances and while providing Medication-Assisted Treatment (MAT). Clinical decisions based on UDT results allow clinicians and patients to accept accountability, document compliance with treatment planning and minimize diversion. This resource presents seven different cases that provide examples of how urine drug testing can impact the clinical outcome of a cases. Drug screens can be done to identify illicit substance or prescription medications that should not be present or can be used to identify controlled prescribed medications that SHOULD be present.
Access “Substance Use Disorder Case Studies: Drug Testing, Toxicology and Forensic Medicine” at: https://pcssnow.org/event/substance-use-disorder-case-studies-drug-testing-toxicology-and-forensic-medicine/